Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.30p
   
  • Change Today:
    -0.15p
  • 52 Week High: 14.13
  • 52 Week Low: 3.23
  • Currency: UK Pounds
  • Shares Issued: 132.35m
  • Volume: 607,805
  • Market Cap: £4.37m
  • RiskGrade: 435

Deal with Barclays    Trade now with Barclays Stockbrokers

Regulatory News

Incorporation of Inaphaea BioLabs Limited 01-Mar-2023 07:00 RNS
Second Price Monitoring Extn 24-Feb-2023 16:40 RNS
Price Monitoring Extension 24-Feb-2023 16:35 RNS
Result of GM, Issue of Equity 02-Feb-2023 12:45 RNS
Operational Update 31-Jan-2023 07:02 RNS
Holding(s) in Company 31-Jan-2023 07:00 RNS
Broker Offer Results 17-Jan-2023 16:36 RNS
Posting of Circular and Notice of General Meeting 17-Jan-2023 09:22 RNS
Launch of Broker Offer 13-Jan-2023 07:01 RNS
Issue of Equity & Proposed Broker Offer 13-Jan-2023 07:00 RNS
Holding(s) in Company 14-Dec-2022 17:01 RNS
Holding(s) in Company 07-Dec-2022 13:06 RNS
Second Price Monitoring Extn 06-Dec-2022 16:40 RNS
Price Monitoring Extension 06-Dec-2022 16:35 RNS
Quarterly Operational and Strategy Update 06-Dec-2022 07:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 3.30p
Change Today -0.15p
% Change -4.35 %
52 Week High 14.13
52 Week Low 3.23
Volume 607,805
Shares Issued 132.35m
Market Cap £4.37m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.92% below the market average18.92% below the market average18.92% below the market average18.92% below the market average18.92% below the market average
13.21% above the sector average13.21% above the sector average13.21% above the sector average13.21% above the sector average13.21% above the sector average
Price Trend
93.92% below the market average93.92% below the market average93.92% below the market average93.92% below the market average93.92% below the market average
89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average
Income Not Available
Growth Not Available

Valirx Dividends

No dividends found

Trades for 25-Apr-2024

Time Volume / Share Price
16:13 85,000 @ 3.30p
16:13 25,000 @ 3.30p
15:15 1,837 @ 3.30p
14:02 25,000 @ 3.30p
13:58 30,000 @ 3.30p

Valirx Key Personnel

CFO Gerald Desler
CEO Suzanne Dilly

Top of Page